Breast Cancer

• CLINICAL_TRIALS research · 2025-08-20
  Clinical Trial Update: Body Awareness, Upper Extremity Function, and Quality of Life in Breast Cancer Survivors

  A clinical trial titled 'Body Awareness, Upper Extremity Function, and Quality of Life in Breast Cancer Survivors' is currently recruiting. …

• CLINICAL_TRIALS research · 2025-08-20
  Clinical Trial Update: Intraoperative Detection of Breast Cancer by Electrosurgical Gas Analysis and Artificial Intelligence

  A clinical trial led by Pontificia Universidad Catolica de Chile is evaluating intraoperative detection of breast cancer using electrosurgic…

• CLINICAL_TRIALS research · 2025-08-20
  Clinical Trial Update: Treatment Intermittent Periods Based on ctDNA-MRD（Circulating Tumor DNA-minimal Residual Disease） Status in Advanced HER2-Positive Breast Cancer

  This is a clinical trial update about intermittent treatment periods guided by ctDNA-MRD status in advanced HER2-positive breast cancer. The…

• CLINICAL_TRIALS research · 2025-08-19
  Clinical Trial Update: A Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer [Phase 2]

  Phase 2 neoadjuvant trial evaluating TQB2102 for HER2-positive breast cancer is currently active but not recruiting.

• CLINICAL_TRIALS research · 2025-08-19
  Clinical Trial Update: WISH, Feasibility of a Factorial Design [NA]

  ClinicalTrials.gov update for the WISH study, a feasibility factorial-design trial sponsored by The University of Tennessee, Knoxville, invo…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2025-08-19
  Clinical Trial Update: Atezolizumab + Sacituzumab Govitecan to Prevent Recurrence in TNBC (ASPRIA) [Phase 2]

  Phase 2 trial ASPRIA is evaluating atezolizumab plus sacituzumab govitecan to prevent recurrence in triple-negative breast cancer, including…

• CLINICAL_TRIALS research · 2025-08-19
  Clinical Trial Update: Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA) [Phase 3]

  Phase 3 clinical trial investigating elacestrant for estrogen receptor-positive, HER2-negative breast cancer with ctDNA relapse (TREAT ctDNA…

• CLINICAL_TRIALS research · 2025-08-19
  Clinical Trial Update: Phosphatidylinositol Glycan Anchor Biosynthesis Class U Protein in Breast Cancer

  Assiut University lists a planned clinical trial evaluating the Phosphatidylinositol Glycan Anchor Biosynthesis Class U Protein in breast ca…

• CLINICAL_TRIALS research · 2025-08-19
  Clinical Trial Update: Intraoperative Radiation Therapy (IORT) in DCIS [NA]

  Clinical trial update indicating a Columbia University-sponsored study evaluating intraoperative radiation therapy for ductal carcinoma in s…

• CLINICAL_TRIALS research · 2025-08-19
  Clinical Trial Update: Comparison of Different Methods of CAPTure of Circulating Tumour Cells (CTC) in Patients With Metastatic Breast or Prostate Cancer [NA]

  A recruiting clinical trial comparing different methods for capturing circulating tumor cells in patients with metastatic breast cancer or m…

• CLINICAL_TRIALS research · 2025-08-17
  Clinical Trial Update: Clinico-biological Data Collection Study of Metastatic Breast Cancer [NA]

  This is a clinico-biological data collection study in metastatic breast cancer that is currently active but not recruiting; it appears to be…

• CLINICAL_TRIALS research · 2025-08-17
  Clinical Trial Update: Gut Microbiome, Adverse Effects, and Markers Through MEtabolic Reprogramming [NA]

  A Johns Hopkins-sponsored clinical trial investigating gut microbiome changes, adverse effects, and metabolic markers in breast cancer patie…

• CLINICAL_TRIALS research · 2025-08-17
  Clinical Trial Update: Phase II/III Study of SPH4336 Combined With Letrozole vs Placebo Combined With Letrozole in First-line Treatment of Breast Cancer [Phase 2, Phase 3]

  Clinical trial update for a phase II/III study evaluating SPH4336 plus letrozole versus placebo plus letrozole as first-line treatment in lo…

• CLINICAL_TRIALS research · 2025-08-17
  Clinical Trial Update: Rowing Following Breast Cancer Chemotherapy [NA]

  Clinical trial investigating rowing exercise after chemotherapy for breast cancer is currently recruiting at the University of Florida. The …

• CLINICAL_TRIALS research · 2025-08-15
  Clinical Trial Update: Identification of Breast Cancer in Breath Samples Using Trained Detection Dogs

  A clinical trial is evaluating whether trained detection dogs can identify breast cancer from breath samples. The study is currently recruit…

• CLINICAL_TRIALS research · 2025-08-15
  Clinical Trial Update: SHR2554 Combined With Endocrine Therapy in Advanced Breast Cancer [Phase 2]

  A Phase 2 clinical trial is evaluating SHR2554 in combination with endocrine therapy for advanced breast cancer, which is currently not yet …

• CLINICAL_TRIALS research · 2025-08-15
  Clinical Trial Update: Randomized, Open, Controlled, Multicenter Phase III Clinical Study of Fluzoparib in Combination With Apatinib Versus Investigator-Selected Chemotherapy for HRD-Positive/HER2-negative Advanced Breast Cancer [Phase 3]

  A Phase III randomized trial is evaluating Fluzoparib in combination with Apatinib versus investigator-selected chemotherapy for HRD-positiv…

• CLINICAL_TRIALS research · 2025-08-15
  Clinical Trial Update: A Study on the Treatment of Early Small Breast Cancer With Ultrasound-guided Vacuum-assisted Excision Combined With Surgery [NA]

  This document reports a clinical trial evaluating ultrasound-guided vacuum-assisted excision combined with surgery for early breast cancer, …

• CLINICAL_TRIALS research · 2025-08-14
  Clinical Trial Update: Impact of 18F-FES PET on the Therapeutic Treatment of Patients With Metastatic Breast Cancer [Phase 4]

  Phase 4 clinical trial update evaluating whether 18F-FES PET imaging can influence therapeutic decisions for patients with metastatic breast…

• CLINICAL_TRIALS research · 2025-08-14
  Clinical Trial Update: Clinical Trial of TQB2102 for Injection Versus Trastuzumab Emtansine for Injection in HER2-positive Advanced Breast Cancer [Phase 3]

  Phase 3 trial comparing TQB2102 to Trastuzumab Emtansine for HER2-positive metastatic breast cancer is currently recruiting.

• CLINICAL_TRIALS research · 2025-08-14
  Clinical Trial Update: The Effect of Walking and Grounding in Women With Breast Cancer [NA]

  A clinical trial entry for a study on the effects of walking and grounding in women with breast cancer; currently recruiting.

• CLINICAL_TRIALS research · 2025-08-14
  Clinical Trial Update: Psychological Well-being in Patients With Breast Cancer

  This document reports a clinical trial evaluating psychological well-being in patients with breast cancer that is currently recruiting.

• CLINICAL_TRIALS research · 2025-08-14
  Clinical Trial Update: A Targeted Electronic Health Approach to Reduce Fear of Recurrence in Breast Cancer Survivors (FoRtitude) [NA]

  The FoRtitude trial tests a targeted electronic health intervention to reduce fear of cancer recurrence among breast cancer survivors. The s…

• CLINICAL_TRIALS research · 2025-08-14
  Clinical Trial Update: PERformance of Multi-Cancer Early-detectIon Based on Various Biomarkers in fEmale BREAST Cancers, PERCEIVE-BREAST

  This record reports an active-not-recruiting clinical trial called PERCEIVE-BREAST, studying multi-cancer early-detection biomarkers with a …

• CLINICAL_TRIALS research · 2025-08-13
  Clinical Trial Update: Breast Cancer Risk Investigation in Grown-up Hodgkin Lymphoma Patients Treated With MBVD. Multicenter Retrospective Study on ≥200 Adult Female HL Patients Treated With ≥1 MBVD Cycle (NPLD, Bleomycin, Vinblastine, Dacarbazine). It Investigates Breast Cancer Incidence Post-treatment.

  This multicenter retrospective study evaluates the incidence of breast cancer in adult female Hodgkin lymphoma survivors treated with MBVD (…